What do you do after you have launched a spinout that has raised venture capital from illustrious backers such as pharmaceutical firm Novo, care provider Kaiser Permanente and medical device manufacturer St Jude Medical, and successfully gone public through a $107m initial public offering?

You do it again, of course. Uday Kumar, an adjunct professor in bioengineering at Stanford University, may sound familiar if you have been reading Global University Venturing for a while: his previous venture, arrhythmia diagnostics technology producer iRhythm Technologies, won the GUV Award for Exit of the Year in 2017. That spinout, founded in 2006,…

The rest of this content is only accessible to Subscribers.

This content is only accessible to subscribers. If you are a subscriber, please sign in. Otherwise, if you would like to try before you buy and haven't previously taken out a free trial, you can do so below. You can also see details on subscriptions by clicking the Subscription Options button.